American Society of Clinical Oncology

SHERPA: White

People

  1. Horwitz
    Horwitz
  2. Noy
    Noy
  3. Zelenetz
    Zelenetz
  4. Hamlin
    Hamlin
  5. Moskowitz
    Moskowitz
  6. Palomba
    Palomba
  7. Epstein
    Epstein
  8. Markowitz
    Markowitz
  9. Papanicolaou
    Papanicolaou
  10. Perales
    Perales

Groups

  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies, Division of (14)
  4. Lymphoma (14)
  5. Population Sciences Research Program (5)
  6. Executive Committee, Center for Hematologic Malignancies (2)
  7. Survivorship Research (2)
  8. Advanced Practice Providers (1)
  9. Bone Marrow Transplant (1)
  10. Division of Subspecialty Medicine (1)
Search Within
  1. "2013"
  2. "Lymphoma"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (14)
  2. Department of Medicine (14)
  3. Hematologic Malignancies, Division of (14)
  4. Lymphoma (14)
  5. Population Sciences Research Program (5)
  6. Executive Committee, Center for Hematologic Malignancies (2)

More Groups

People
  1. Ariela Noy (5)
  2. Steven Horwitz (5)
  3. Andrew Zelenetz (3)
  4. Paul Hamlin (3)
  5. Alison Moskowitz (2)
  6. Anas Younes (2)

More People

Years
  1. 2013 (14)
Publications
  1. Journal of Clinical Oncology (13)
  2. American Society of Clinical Oncology Educational Book (1)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SGN-75 in the treatment of patients with CD70-positive malignancies including metastatic renal cell carcinoma
    Meeting Abstract

    Thompson, J. A.; Forero, A.; Heath, E. I.; Pal, S. K.; Ansell, S. M.; Infante, J. R.; De Vos, S.; Hamlin, P. A.; Whiting, N. C.; Zhao, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Infectious disease associations in advanced stage, indolent lymphoma (follicular, FL, and nonfollicular, nFL): A prospective trial of antibiotic therapy
    Meeting Abstract

    Portlock, C. S.; Hamlin, P. A.; Gerecitano, J. F.; Noy, A.; Palomba, M. L.; Walkley, J.; Corcoran, S.; Papanicolaou, G. A.; Markowitz, A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with relapsed/refractory CLL
    Meeting Abstract

    Patel, M. R.; Kahl, B. S.; Horwitz, S. M.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Faia, K.; Kelly, P. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial
    Meeting Abstract

    O'Connor, O. A.; Masszi, T.; Savage, K. J.; Pinter-Brown, L. C.; Foss, F. M.; Popplewell, L.; Cashen, A. F.; Doorduijn, J.; Chawla, S.; Knoblauch, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of the selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor idelalisib (GS-1101) in combination with rituximab (R) in treatment-naive patients (pts) ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    O'Brien, S. M.; Lamanna, N.; Kipps, T. J.; Flinn, I.; Zelenetz, A. D.; Burger, J. A.; Holes, L.; Johnson, D. M.; Gu, J.; Dansey, R. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Medical oncologists' clinical experiences and comfort levels with 20 recently approved agents
    Meeting Abstract

    Love, N.; Anderson, K. C.; Flaherty, K.; Kantarjian, H. M.; Lynch, T. J.; O'Shaughnessy, J.; Sartor, A. O.; Venook, A. P.; Zelenetz, A. D.; Moss, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of ISIS 481464 (AZD9150), a first-in-human, first-in-class, antisense oligonucleotide inhibitor of STAT3, in patients with advanced cancers
    Meeting Abstract

    Hong, D. S.; Younes, A.; Fayad, L.; Fowler, N. H.; Hagemeister, F. B.; Mistry, R.; Nemunaitis, J. J.; Borad, M. J.; Bryce, A. H.; Yamashita, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ in patients with relapsed/refractory lymphoma
    Meeting Abstract

    Horwitz, S. M.; Flinn, I.; Patel, M. R.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Dunbar, J.; Kelly, P. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pooled analysis of 1,546 patients with AIDS-related lymphoma (ARL): An assessment of prognostic factors by treatment era
    Meeting Abstract

    Barta, S. K.; Samuel, M.; Xue, X.; Lee, J. Y.; Mounier, N.; Kaplan, L. D.; Ribera, J. M.; Spina, M.; Tirelli, U.; Weiss, R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Antibody-drug conjugates in hematologic malignancies
    Journal Article

    Leslie, L. A.; Younes, A.
    American Society of Clinical Oncology Educational Book (2013)

    Fulltext@MSK | Save